Chronic Lymphocytic Leukemia — 5-Minute Journal Club: Microlearning Activity 1

Featuring perspectives from Dr Mazyar Shadman, including the following topics:
• The CLL17 trial: Fixed-duration versus continuous targeted treatment for previously untreated chronic lymphocytic leukemia (CLL) (0:00)
• The AMPLIFY trial: Fixed-duration acalabrutinib combinations for untreated CLL (5:31)
• Zanubrutinib-based therapy for treatment-naïve CLL (12:32)

CME information and select publications (researchtopractice.com/CLLMicro2025/5MJC/1/Video)